Oxycontin sr 30mg - OxyContin: Indications, Side Effects, Warnings - lebeauty88-website.avengosoft.com
Never share oxycodone with another person, especially someone with a history of drug abuse or addiction. Keep the medication 30mg a place oxycontin others cannot get to it, oxycontin sr 30mg.
To make sure oxycodone is safe for you, tell your doctor if you have: FDA pregnancy category B. Oxycodone is not expected to harm an unborn baby.
However, oxycodone may cause breathing problems, oxycontin sr 30mg, or addiction and withdrawal symptoms in your newborn if you take the medication during pregnancy. Tell your doctor if you are pregnant or plan to become pregnant.
Adult Indications and Usage
Oxycodone can pass into breast milk and may harm a nursing baby. You should not breast-feed while you are using oxycodone. Older adults may be 30mg likely to have side effects from this oxycontin. How should I use oxycodone? Follow all directions on your prescription label, oxycontin sr 30mg.
Never take this medicine in larger amounts, or for longer than prescribed. Tell your doctor if the medicine seems to stop working as well in relieving your pain. Do not crush, chew, or break an extended-release tablet. If your doctor has told you to take two or more oxycodone tablets per dose, gia thuoc clarithromycin stada 500mg the tablets one at a time.
Do not wet, presoak, or lick the tablet before placing it in your mouth. Drink plenty of water to make swallowing easier and to prevent choking.
Measure liquid medicine with a special dose-measuring spoon or 30mg cup, oxycontin sr 30mg. Concomitant use of OxyContin with Oxycontin inducers or discontinuation of a CYP3A4 inhibitor could decrease oxycodone plasma concentrations, decrease opioid 30mg or, possibly, lead to a withdrawal syndrome oxycontin a patient who had developed physical dependence to oxycodone. Monitor patients closely at frequent intervals and consider increasing the opioid dosage if needed to maintain adequate analgesia or if symptoms of opioid withdrawal occur.
Profound sedation, respiratory depression, oxycontin sr 30mg, coma, and death may result from the concomitant use of OxyContin with benzodiazepines or CNS depressants e, oxycontin sr 30mg.
Because of these risks, oxycontin sr 30mg, reserve concomitant prescribing of these 30mg for use in patients for whom alternative treatment options are inadequate. If the decision is made to prescribe a benzodiazepine or other CNS depressant concomitantly with an opioid analgesic, prescribe the lowest effective dosages and minimum durations of concomitant use.
In patients already receiving an opioid analgesic, prescribe a lower initial dose of the benzodiazepine or other CNS depressant than indicated in the absence of an opioid, and titrate based on clinical response.
OxyContin Dosage
If an opioid analgesic is initiated in a patient already taking a benzodiazepine or other CNS depressant, oxycontin sr 30mg, prescribe a lower initial dose of the opioid analgesic, and titrate based on clinical response. Follow patients closely for signs and symptoms of respiratory depression and sedation.
Advise both patients and caregivers about the risks of respiratory depression and sedation when OxyContin is used with benzodiazepines or other CNS depressants including alcohol and illicit drugs.
Advise patients not to drive or operate heavy machinery until the effects of concomitant use of the benzodiazepine or other CNS depressant have been determined.
Screen patients for risk of substance use disorders, including opioid abuse and misuse, and warn them of the risk for overdose and death associated with the use of additional CNS depressants including alcohol and illicit drugs.
The use of OxyContin 30mg patients with acute or severe bronchial asthma in an unmonitored setting or in the absence of resuscitative equipment is contraindicated. OxyContin-treated patients with significant chronic obstructive pulmonary disease or cor pulmonale, oxycontin those with a substantially decreased respiratory reserve, hypoxia, hypercapnia, or pre-existing respiratory depression are at oxycontin risk of decreased respiratory drive including apnea, oxycontin sr 30mg, even at recommended dosages of OxyContin.
Life-threatening respiratory depression is more likely to occur in elderly, cachectic, or debilitated patients because they may have altered 30mg or altered clearance compared to younger, healthier patients, oxycontin sr 30mg.
Monitor such patients closely, particularly when initiating and titrating OxyContin and when OxyContin is given concomitantly with other drugs that depress respiration. Alternatively, consider the use of non-opioid analgesics 30mg these patients. Cases of adrenal insufficiency have been reported with opioid use, oxycontin sr 30mg, more often following greater than one oxycontin of use.
If adrenal insufficiency is suspected, confirm the diagnosis with diagnostic testing as soon as possible. If adrenal insufficiency is diagnosed, treat with physiologic replacement doses of corticosteroids. Wean the patient off of the opioid to allow adrenal function to recover and continue corticosteroid treatment until adrenal function recovers.
30mg OxyContin may cause severe hypotension including orthostatic hypotension and syncope in ambulatory patients, oxycontin sr 30mg. There is an increased risk in patients whose ability to maintain blood pressure has already been compromised by a reduced blood volume or after concurrent administration of certain CNS depressants drugs e. Monitor these patients for signs of hypotension after initiating oxycontin titrating the dosage of OxyContin.
In patients with circulatory shock, OxyContin may cause vasodilation that can further reduce cardiac output and blood pressure. Avoid the use of OxyContin in patients with circulatory shock. In patients who may be susceptible to the intracranial effects of CO2 retention e. Monitor those patients for signs of sedation and respiratory depression, oxycontin sr 30mg, particularly when initiating therapy with OxyContin.
Opioids may obscure the clinical course in a patient with a head injury. Avoid the use of OxyContin in patients with impaired consciousness or coma. There have been post-marketing reports of difficulty swallowing OxyContin tablets. These reports include choking, gagging, regurgitation, and tablets stuck in the throat, oxycontin sr 30mg. Instruct patients not to pre-soak, lick or otherwise wet OxyContin tablets prior to placing in the mouth, and to take one tablet at a time with enough water to ensure complete swallowing immediately after placing in the mouth.
There have been rare post-marketing reports of cases of intestinal obstruction, and exacerbations of diverticulitis, oxycontin sr 30mg, some of which have required medical intervention to remove the tablet. Patients with underlying GI disorders such as esophageal cancer or colon cancer with a small gastrointestinal lumen are at greater risk of developing these complications.
Consider use of an alternative analgesic in patients who have 30mg swallowing and patients at risk for underlying GI disorders resulting in a small gastrointestinal lumen.
OxyContin is contraindicated in patients with known or suspected gastrointestinal obstruction, including paralytic ileus. The oxycodone in OxyContin may cause spasm of the sphincter of Oddi. Opioids may cause increases in the oxycontin amylase. Monitor patients with biliary tract disease, including acute pancreatitis. The oxycodone in OxyContin may increase the frequency of seizures in patients with seizure disorders, and may increase the risk of seizures occurring in other clinical settings associated with seizures.
Monitor patients with a history of seizure disorders for worsened seizure control during OxyContin therapy. When discontinuing OxyContin, 30mg taper the dosage. Oxycontin not abruptly discontinue OxyContin.
OxyContin 5 mg prolonged release tablets
OxyContin may impair the mental or physical abilities needed to perform potentially hazardous activities such as driving a car or operating machinery, oxycontin sr 30mg.
Warn patients not to drive or operate dangerous machinery unless they are tolerant to the effects of OxyContin and know how they will react to the medication. Not every urine drug test for "opioids" or "opiates" detects oxycodone reliably, especially those designed for in-office use.